Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShort-Term Debt repayments
Ratios

Plus Therapeutics (PSTV) Accumulated Depreciation & Amortization (2016 - 2025)

Plus Therapeutics (PSTV) has disclosed Accumulated Depreciation & Amortization for 13 consecutive years, with $3.1 million as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 23.82% to $3.1 million in Q4 2024 year-over-year; TTM through Dec 2024 was $3.1 million, a 23.82% increase, with the full-year FY2024 number at $3.1 million, up 23.82% from a year prior.
  • Accumulated Depreciation & Amortization was $3.1 million for Q4 2024 at Plus Therapeutics, up from $2.5 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $3.1 million in Q4 2024 to a low of $1.4 million in Q4 2020.
  • A 4-year average of $2.3 million and a median of $2.2 million in 2022 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: skyrocketed 35.85% in 2020, then rose 23.82% in 2024.
  • Plus Therapeutics' Accumulated Depreciation & Amortization stood at $1.4 million in 2020, then surged by 41.31% to $2.0 million in 2022, then rose by 29.39% to $2.5 million in 2023, then increased by 23.82% to $3.1 million in 2024.
  • Per Business Quant, the three most recent readings for PSTV's Accumulated Depreciation & Amortization are $3.1 million (Q4 2024), $2.5 million (Q4 2023), and $2.0 million (Q4 2022).